Elixophyllin (Theophylline) for COPD

Overview
Elixophyllin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis. It is sometimes prescribed for treating chronic obstructive pulmonary disease (COPD), particularly when other treatments, such as inhaled bronchodilators, are insufficient in managing COPD symptoms. Elixophyllin is also known by its drug name, theophylline.

Theophylline belongs to the methylxanthine class of drugs. It works by relaxing the smooth muscles in the airways, thereby reducing bronchoconstriction (narrowing of the airways) and improving airflow in the lungs. Additionally, it is believed to suppress the airway’s response to stimuli and increase the contraction of the diaphragm, which can help improve breathing in people with COPD.

How do I take it?
Prescribing information states that Elixophyllin is taken orally in the form of a liquid solution. The dosing schedule typically involves taking the medication every six to 12 hours, depending on a person’s specific needs and response to the treatment. The medication should be taken exactly as prescribed by a health care provider.

Side effects
Common side effects of Elixophyllin include nausea, vomiting, headache, insomnia, and diarrhea. Some people may also experience irritability, restlessness, or tremors. 

Rare but serious side effects may include seizures, significant changes in heart rhythm (such as atrial fibrillation or tachycardia), and persistent vomiting, which may be an early sign of theophylline toxicity. These effects are more likely to occur if the blood levels of theophylline become too high, so it is crucial to follow dosing instructions carefully and to have regular blood tests to monitor drug levels.

For more information about this treatment, visit:

Elixophyllin (Theophylline) — Drugs.com

Theophylline — MedlinePlus